MedTrace Logo

A Novel Noninvasive Thermoregulatory Device for Postural Tachycardia Syndrome

NCT04943276 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 23

Last updated 2024-10-08

No results posted yet for this study

Summary

The investigators hope to learn the feasibility and preliminary efficacy of the Embr device for improving thermal comfort in individuals with POTS and impaired thermoregulation. Feasibility will be assessed via usage of the Embr device and participant feedback. Preliminary efficacy measures will include temperature-related symptoms and temperature- related quality of life in individuals with POTS and impaired thermoregulation.

Conditions

  • Postural Tachycardia Syndrome

Interventions

DEVICE

Embr Device

The Embr thermal device will be worn at all times from study start to the study endpoint.

Sponsors & Collaborators

Principal Investigators

  • Mitchell Miglis · Stanford University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-27
Primary Completion
2023-11-03
Completion
2023-11-03

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04943276 on ClinicalTrials.gov